Literature DB >> 2049578

Interleukin-6 activity in paired samples of synovial fluid. Correlation of synovial fluid interleukin-6 levels with clinical and laboratory parameters of inflammation.

A M Miltenburg1, J M van Laar, R de Kuiper, M R Daha, F C Breedveld.   

Abstract

Paired synovial fluid (SF) samples obtained from the knees of 12 arthritis patients were studied to establish a relation between parameters of local inflammatory activity and SF interleukin-6 (IL-6) levels. Local disease activity was scored using joint temperature, swelling and pain as clinical parameters of inflammation. SF samples were assayed for laboratory parameters of inflammation such as leucocyte content, the percentage polymorphonuclear cells, the pH, and for immunoglobulin levels (IgG, IgM). SF IL-6 concentrations were determined using the B9-bioassay. Within individual patients the local activity of inflammation as measured using clinical parameters was found to be related to the local SF IL-6 level. When considering the total group of patients, a correlation (P less than 0.001) was found between the clinical parameters of local inflammation and the SF IL-6 levels. Furthermore, IL-6 levels were found to correlate with leucocyte counts (P less than 0.02), the percentage of polymorphonuclear cells (P less than 0.10), the pH value (P less than 0.01), but not with SF IgM and IgG concentrations.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2049578     DOI: 10.1093/rheumatology/30.3.186

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  7 in total

1.  Agalactosyl IgG in pristane-induced arthritis. Pregnancy affects the incidence and severity of arthritis and the glycosylation status of IgG.

Authors:  S J Thompson; Y Hitsumoto; Y W Zhang; G A Rook; C J Elson
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

2.  Evaluation of interleukin-6 in rheumatoid arthritis as an activity criterion.

Authors:  T Sentürk; G Kinikli; M Turgay; H Tutkak; M Duman; G Tokgöz
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

3.  Levels of soluble receptors for tumor necrosis factor type I and type II in paired synovial fluids of arthritis patients.

Authors:  A M Miltenburg; D Aderka; J M van Laar; D Wallach; F C Breedveld
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

4.  Do synovial fluid acute phase proteins from patients with rheumatoid arthritis originate from serum?

Authors:  E C Havenaar; R J Dolhain; G A Turner; M T Goodarzi; E C van Ommen; F C Breedveld; W van Dijk
Journal:  Glycoconj J       Date:  1997-06       Impact factor: 2.916

5.  Interleukin-8 (IL-8) in synovial fluid of rheumatoid and nonrheumatoid joint effusions.

Authors:  C A Verburgh; M H Hart; L A Aarden; A J Swaak
Journal:  Clin Rheumatol       Date:  1993-12       Impact factor: 2.980

6.  Association of serum markers with improvement in clinical response measures after treatment with golimumab in patients with active rheumatoid arthritis despite receiving methotrexate: results from the GO-FORWARD study.

Authors:  Sudha Visvanathan; Mahboob U Rahman; Edward Keystone; Mark Genovese; Lars Klareskog; Elizabeth Hsia; Michael Mack; Jacqui Buchanan; Michael Elashoff; Carrie Wagner
Journal:  Arthritis Res Ther       Date:  2010-11-17       Impact factor: 5.156

7.  Long-term study of the impact of methotrexate on serum cytokines and lymphocyte subsets in patients with active rheumatoid arthritis: correlation with pharmacokinetic measures.

Authors:  Joel M Kremer; David A Lawrence; Robert Hamilton; Iain B McInnes
Journal:  RMD Open       Date:  2016-06-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.